Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Mastocytosis × Injections × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 2 Thoracic Neoplasms 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Myelodysplastic Syndromes 1 Mastocytosis 1 Liver Neoplasms 1 Gastroenteropancreatic Neuroendocrine Tumors 1 GATA2 Deficiency 1 Colorectal Neoplasms 1 Carcinoma, Hepatocellular 1 Advanced Solid Tumor 1

Interventions

Injections 1 Cladribine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01333293 2016-01-18

XOLMA

University of Zurich

Phase 2/3 Completed

Mastocytosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡